Automating MetaboQuan-R and LipidQuan Data Processing with Symphony

Importance of the Topic

Advances in targeted metabolomic and lipidomic analyses are critical for identifying biomarkers in large cohort studies. The MetaboQuan-R and LipidQuan assays provide structured workflows for semi-quantitative screening of small molecules and lipids, respectively. High-throughput automation of data processing reduces manual intervention, supporting reproducibility and accelerating discovery in fields such as disease profiling and quality control.

Objectives and Study Overview

This work demonstrates an automated pipeline using Symphony software to process LC-MS datasets generated by MetaboQuan-R and LipidQuan assays. The goal is to integrate data acquisition in MassLynx with automated processing in TargetLynx or Skyline, convert outputs to formats compatible with MetaboAnalyst, and produce ready-to-use statistical reports immediately after acquisition.

Methodology and Instrumentation

Samples are analyzed by Waters LC-MS systems controlled by MassLynx. Symphony pipelines monitor acquisition queues, transfer raw data files to a processing server, and trigger custom workflows. Processing steps include:

• TargetLynx processing: export .xml results and conversion to .csv via Excel macros.
• Skyline processing: import raw data, apply peak integration and normalization, and export .csv results.

All methods utilize predefined LC gradients and spectral libraries from the Quanpedia database, requiring no additional method development.

Main Results and Discussion

Automated workflows generate standardized results files compatible with MetaboAnalyst for downstream statistical analysis. In a case study comparing lung and bladder cancer plasma cohorts, over 28 amino acid features were processed through the Skyline pipeline, revealing significant alterations (FDR < 1%), including elevated sarcosine levels in both cancers. The approach reduced hands-on time, minimized error, and supported rapid biomarker discovery.

Benefits and Practical Applications

Key advantages include:

• Increased sample throughput by eliminating manual data handling.
• Enhanced reproducibility and traceability via automated logs.
• Immediate availability of analysis-ready files for multivariate statistics.
• Scalability for large cohorts in clinical research and QA/QC environments.

Future Trends and Opportunities

Future developments may incorporate cloud-based processing and integration with additional bioinformatics platforms. Machine learning algorithms could be embedded to flag atypical results in real time. Expansion of the Symphony task library to include emerging assays will further streamline workflows in metabolomics and lipidomics.

Conclusion

The Symphony-driven automation of MetaboQuan-R and LipidQuan data processing significantly boosts efficiency and data consistency. By coupling MassLynx acquisition with TargetLynx or Skyline processing and direct export to MetaboAnalyst formats, laboratories can accelerate high-throughput studies and foster rapid biomarker identification.

References

1. Chong J. et al. MetaboAnalyst 4.0: Towards more Transparent and Integrative Metabolomics Analysis. Nucleic Acids Research, 2018. DOI:10.1093/nar/gky310
2. Waters Corporation. Rapid Molecular Profiling of a Bladder and Lung Cancer Human Plasma Cohort using MetaboQuan-R. 720006612EN, 2019.